DivcoWest Welcomes Cerevel Therapeutics to Cambridge Crossing

Cambridge, MA, (Aug 07, 2019) – DivcoWest announced today that it has signed a 59,865 square-foot lease with Cerevel Therapeutics at Cambridge Crossing (CX), the new and connected neighborhood at the intersection of Cambridge, Somerville, and Boston. Dedicated to bringing cutting-edge solutions to individuals impacted by nervous system diseases, the bio-pharmaceutical company will join Philips North America at 222 Jacobs Street in 2020, making it the third fully leased commercial building at CX.

READ PRESS RELEASE

Events

Learn more about our events on our Facebook page

News

  • Reflecting Back & Looking Forward: Meaningful Milestones at CX Since Breaking Ground

    Cambridge Crossing //
  • Bringing the Community Together at Cambridge Crossing: CX Summer Nights 2019

    Cambridge Crossing //
  • Making History: Parcel G Concrete Pour

    Cambridge Crossing //
  • Biotech Community Unites at CX For A Great Cause

    Cambridge Crossing //
  • Connecting Cambridge’s Future to its Past: Honoring Harriet Ann Jacobs & Gertrude Wright Morgan

    Cambridge Crossing //
  • Pfizer spinoff Cerevel moving into Cambridge Crossing

    Boston Globe //
  • Renowned Local Chef Will Gilson to Introduce Multi-Concept Restaurant to Cambridge Crossing

    Cambridge Crossing //
  • City of Cambridge, in Partnership with DivcoWest, Renames Two Streets in Honor of Prominent Historical Women

    Cambridge Crossing //
  • Cambridge honors two in the struggle for equality.

    Boston Globe //
  • To stay competitive, developers and landlords are being driven to add telecommunications infrastructure and sophisticated building technology

    New York Times //